SCHEMBL4606300

SCHEMBL4606300

CCC(=O)Nc1ccc(Oc2ccccc2N2CCCCC2)cc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.51
NPSR1 Q6W5P4 5/20 0.47
LMNA P02545 3/20 0.47
TSHR P16473 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MAPK1 P28482 3/20 0.47
MAPT P10636 3/20 0.47
ATM Q13315 2/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
ALOX15 P16050 1/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
GAA P10253 4/20 0.46
ALDH1A1 P00352 2/20 0.46
SLC22A1 O15245 1/20 0.45
ABCC3 O15438 1/20 0.45
ABCC4 O15439 1/20 0.45
NR1I2 O75469 1/20 0.45
ABCB11 O95342 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4606133 0.91 MEN1 (0.48) TSHRMAPK1MAPTPOLBKMT2A
SCHEMBL4605187 0.90 L3MBTL1 (0.52) NPC1NPSR1LMNATSHRL3MBTL1
SCHEMBL4603916 0.85 NPC1 (0.52) NPC1NPSR1LMNATSHRL3MBTL1
SCHEMBL4606153 0.85 NPSR1 (0.48) NPC1NPSR1LMNATSHRL3MBTL1
SCHEMBL4604249 0.82 POLB (0.54) L3MBTL1ATMPOLBGAAALDH1A1
SCHEMBL4603669 0.82 ALDH1A1 (0.53) L3MBTL1ATMPOLBKMT2AMEN1
SCHEMBL4604342 0.78 KDM4E (0.49) L3MBTL1ATMPOLBGAAALDH1A1
SCHEMBL4605135 0.78 KDM4E (0.49) NPC1LMNAL3MBTL1MAPK1MAPT
SCHEMBL4605497 0.78 ALDH1A1 (0.46) NPC1NPSR1LMNATSHRL3MBTL1
SCHEMBL4604961 0.78 ALDH1A1 (0.48) NPC1LMNAL3MBTL1MAPTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720825-B1 ANTHRANILIC ACID DERIVATIVES, METHODS FOR THEIR PREPARATION AND USE AS DHODH INHIBITORS ACTIVE BIOTECH AB (SE) 2008-07-09 EP disclosed
US-7074831-B2 Compounds, methods for their preparation and use thereof ACTIVE BIOTECH AB (SE) 2006-07-11 US disclosed
US-20050187297-A1 New compounds, methods for their preparation and use thereof ACTIVE BIOTECH AB (SE) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187297-A1 New compounds, methods for their preparation and use thereof MALT1, TPMT, FUCA1 NPC1 2040/4885NPSR1 3825/4885LMNA 4153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.